Alvimedica and CID join forces


Alvimedica has announced a merger with CID (Carbostent & Implantable Devices). Under the brand name Alvimedica, the companies aim to be a new European alternative in the global market for medical devices.

According to an Alvimedica press release, Alvimedical now owns three centres of excellence in research and develpment across three different European sites: Catalca, Turkey; Saluggia, Italy; and Assen, the Netherlands. The press release also reports that the CID product portfolio is “fully complementary” to the cardiovascular product line currently marketed by Alvimedica.